Search results
Added:
2 months ago
Source:
Radcliffe Cardiology
A prespecified secondary analysis of the DANFLU-2 trial suggests that a high-dose inactivated influenza vaccine (HD-IIV) may offer greater protection against cardiovascular-related hospitalisations in older adults compared to a standard-dose vaccine (SD-IIV).¹˒² While the trial’s primary endpoint was not met, these exploratory findings point to a potential benefit in reducing the burden of…
View more
Added:
3 months ago
Source:
Radcliffe Cardiology
A large-scale, nationwide study from South Korea suggests that vaccination with the live zoster vaccine is associated with a significantly lower risk of various cardiovascular (CV) events in adults aged 50 and older. The findings indicate a protective association that persists for up to 8 years post-vaccination.¹This population-based cohort study analysed data from over 2.2 million individuals…
View more
Red Flags in Acute Myocarditis
Author(s):
Shahrukh Hashmani
,
Yosef Manla
,
Nadya Al Matrooshi
,
et al
Added:
1 year ago
Article
Author(s):
Angela Cozma
,
Violeta Briciu
,
Adela Viviana Sitar-Tăut
,
et al
Added:
7 months ago
Orly Vardeny
Research Area(s) / Expertise:
Author
Expertise
Sanjay Prasad
Job title: Consultant in cardiology and cardiovascular magnetic resonance Professor of cardiomyopathy
Author
Daniel Bromage
Research Area(s) / Expertise:
Author
Expertise
Akshay S Desai
Research Area(s) / Expertise:
Author
Expertise
Evandro de Azambuja
Research Area(s) / Expertise:
Job title: Head of the Medical Support Team, Jules Bordet Insitute, Brussels, Belgium
Author
Garrick C Stewart
Research Area(s) / Expertise:
Author
